Bogdan Mihai MARIS

Prof. Bogdan Mihai MARIS

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2021 in Current Robotics Reports
Verified
Journal Article
Open access
PDF file
FSFrançoise J. Siepel
Françoise J. Siepel
BMBogdan Mihai MARIS
Bogdan Mihai MARIS
MWMarcel K. Welleweerd
Marcel K. Welleweerd
VGVincent Groenhuis
Vincent Groenhuis
PFPaolo Fiorini
Paolo Fiorini
SSStefano Stramigioli
Stefano Stramigioli
Purpose of the review: Robotics is a rapidly advancing field, and its introduction in healthcare can have a multitude of benefits for clinical practice. Especially, applications depending on the radiologist’s accuracy and precision, such as percutaneous interventions, may profit. This paper provides an overview of recent robot-assisted percutaneous solutions. Recent findings: Percutaneous interventions are relatively simple and the quality of the procedure increases a lot by introducing robotics due to the improved accuracy and precision. The success of the procedure is heavily dependent on the ability to merge pre- and intraoperative images, as an accurate estimation of the current target location allows to exploit the robot’s capabilities. Summary: Despite much research, the application of robotics in some branches of healthcare is not commonplace yet. Recent advances in percutaneous robotic solutions and imaging are highlighted, as they will pave the way to more widespread implementation of robotics in clinical practice.

11 January 2021 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
ANAnton V. Nikolaev
Anton V. Nikolaev
LJLeon de Jong
Leon de Jong
GWGert Weijers
Gert Weijers
VGVincent Groenhuis
Vincent Groenhuis
RMRitse M. Mann
Ritse M. Mann
CKChris L. de Korte
Chris L. de Korte
Breast cancer is one of the most diagnosed types of cancer worldwide. Volumetric ultrasound breast imaging, combined with MRI can improve lesion detection rate, reduce examination time, and improve lesion diagnosis. However, to our knowledge, there are no 3D US breast imaging systems available that facilitate 3D US - MRI image fusion. In this paper, a novel Automated Cone-based Breast Ultrasound System (ACBUS) is introduced. The system facilitates volumetric ultrasound acquisition of the breast in a prone position without deforming it by the US transducer. Quality of ACBUS images for reconstructions at different voxel sizes (0.25 and 0.50 mm isotropic) was compared to quality of the Automated Breast Volumetric Scanner (ABVS) (Siemens Ultrasound, Issaquah, WA, USA) in terms of signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and resolution using a custom made phantom. The ACBUS image data were registered to MRI image data utilizing surface matching and the registration accuracy was quantified using an internal marker. The technology was also evaluated in vivo. The phantom-based quantitative analysis demonstrated that ACBUS can deliver volumetric breast images with an image quality similar to the images delivered by a currently commercially available Siemens ABVS. We demonstrate on the phantom and in vivo that ACBUS enables adequate MRI-3D US fusion. To our conclusion, ACBUS might be a suitable candidate for a second-look breast US exam, patient follow-up, and US guided biopsy planning.

5 July 2021 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Open access
PDF file
BMBogdan Mihai MARIS
Bogdan Mihai MARIS
CTChiara Tenga
Chiara Tenga
RVRudy Vicario
Rudy Vicario
LPLuigi Palladino
Luigi Palladino
NMNoe Murr
Noe Murr
PFPaolo Fiorini
Paolo Fiorini
Purpose: We present the validation of PROST, a robotic device for prostate biopsy. PROST is designed to minimize human error by introducing some autonomy in the execution of the key steps of the procedure, i.e., target selection, image fusion and needle positioning. The robot allows executing a targeted biopsy through ultrasound (US) guidance and fusion with magnetic resonance (MR) images, where the target was defined. Methods: PROST is a parallel robot with 4 degrees of freedom (DOF) to orient the needle and 1 DOF to rotate the US probe. We reached a calibration error of less than 2 mm, computed as the difference between the needle positioning in robot coordinates and in the US image. The autonomy of the robot is given by the image analysis software, which employs deep learning techniques, the integrated image fusion algorithms and automatic computation of the needle trajectory. For safety reasons, the insertion of the needle is assigned to the doctor. Results: System performance was evaluated in terms of positioning accuracy. Tests were performed on a 3D printed object with nine 2-mm spherical targets and on an anatomical commercial phantom that simulates human prostate with three lesions and the surrounding structures. The average accuracy reached in the laboratory experiments was $$ 1.30 \pm 0.44\, \text {mm}$$ 1.30 ± 0.44 mm in the first test and $$ 1.54 \pm 0.34\, \text {mm}$$ 1.54 ± 0.34 mm in the second test. Conclusions: We introduced a first prototype of a prostate biopsy robot that has the potential to increase the detection of clinically significant prostate cancer and, by including some level of autonomy, to simplify the procedure, to reduce human errors and shorten training time. The use of a robot for the biopsy of the prostate will create the possibility to include also a treatment, such as focal ablation, to be delivered through the same system.

13 June 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
SMSanam Daneshpour Moghadam
Sanam Daneshpour Moghadam
BMBogdan Mihai MARIS
Bogdan Mihai MARIS
Ali MokhtariAli Mokhtari
Ali Mokhtari
CDClaudia Daffara
Claudia Daffara
PFPaolo Fiorini
Paolo Fiorini
Optical Coherence Tomography (OCT) is a relatively new medical imaging device that provides high-resolution and real-time visualization of biological tissues. Initially designed for ophthalmology, OCT is now being applied in other types of pathologies, like cancer diagnosis. This review highlights its impact on disease diagnosis, biopsy guidance, and treatment monitoring. Despite its advantages, OCT has limitations, particularly in tissue penetration and differentiating between malignant and benign lesions. To overcome these challenges, the integration of nanoparticles has emerged as a transformative approach, which significantly enhances contrast and tumor vascularization at the molecular level. Gold and superparamagnetic iron oxide nanoparticles, for instance, have demonstrated great potential in increasing OCT’s diagnostic accuracy through enhanced optical scattering and targeted biomarker detection. Beyond these innovations, integrating OCT with multimodal imaging methods, including magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound, offers a more comprehensive approach to disease assessment, particularly in oncology. Additionally, advances in artificial intelligence (AI) and biosensors have further expanded OCT’s capabilities, enabling real-time tumor characterization and optimizing surgical precision. However, despite these advancements, clinical adoption still faces several hurdles. Issues related to nanoparticle biocompatibility, regulatory approvals, and standardization need to be addressed. Moving forward, research should focus on refining nanoparticle technology, improving AI-driven image analysis, and ensuring broader accessibility to OCT-guided diagnostics. By tackling these challenges, OCT could become an essential tool in precision medicine, facilitating early disease detection, real-time monitoring, and personalized treatment for improved patient outcomes.

17 January 2023 in IEEE Robotics and Automation Letters
Verified
Journal Article
Open access
SFSandro Ferrari
Sandro Ferrari
ETEleonora Tagliabue
Eleonora Tagliabue
BMBogdan Mihai MARIS
Bogdan Mihai MARIS
PFPaolo Fiorini
Paolo Fiorini
Image-guided biopsy is the most common technique for breast cancer diagnosis. Although magnetic resonance imaging (MRI) has the highest sensitivity in breast lesion detection, ultrasound (US) biopsy guidance is generally preferred due to its non-invasiveness and real-time image feedback during the insertion. In this work, we propose an autonomous robotic system for US-guided biopsy of breast lesions identified on pre-operative MRI. After initial MRI to breast registration, the US probe attached to the robotic manipulator compresses the breast tissues until a pre-determined force level is reached. This technique, known as preloading, will allow to minimize lesion displacement during the needle insertion. Our workflow integrates a deformation compensation strategy based on patient-specific biomechanical model to update the US probe orientation keeping the target lesion on the US image plane during compression. By relying on a deformation model, the proposed system does not require lesion visibility on US. Experimental evaluation is performed to assess the performance of the system on a realistic breast phantom with 15 internal lesions, considering different preloading forces. The deformation compensation strategy allows to improve localization accuracy, and as a consequence final probe positioning, for all considered lesions. Median lesion localization error is 3.3 mm, which is lower than the median lesion radius, when applying a preloading of 2 N, which guarantees both minimal needle insertion error and tissue stress.

14 January 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
Ali MokhtariAli Mokhtari
Ali Mokhtari
BMBogdan Mihai MARIS
Bogdan Mihai MARIS
PFPaolo Fiorini
Paolo Fiorini
This paper reviews the main research on Optical Coherence Tomography (OCT), focusing on the progress and advancements made by researchers over the past three decades in its methods and medical imaging applications. By analyzing existing studies and developments, this review aims to provide a foundation for future research in the field.